FK962

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FK962, covering 2012-06-07 to 2012-06-07. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]